AGP Executive Report
Last update: 7 hours agoMalta & Health Policy: Malta’s underground weight-loss drug market is under scrutiny after reports of unapproved retatrutide being sold via social media, with health authorities warning about falsified, contaminated or wrongly dosed products. Pharma & Regulation: Alkem Labs’ Daman facility has been flagged by the USFDA as Official Action Indicated (OAI) after earlier inspections, though the firm says it continues supplying approved products while working toward compliance. Environment & Conservation: ERA says the Comino hotel project must plant 540 new indigenous trees after protected vegetation is removed, with court appeal still ongoing. Energy & Infrastructure: Interconnect Malta received four submissions for a proposed renewable electricity link from North Africa to Malta, feeding into government feasibility work. Maritime & Security: The AFM Maritime Squadron logged over 10,000 operational hours at sea in 2025, with the home affairs minister visiting the fleet and workshops. EU Science Funding: Eurostat data shows EU public R&D budgets rose to €130.2bn in 2025, but Malta remains among the lowest per-capita spenders (€73.7). AI & Education: Malta’s education debate is shifting from “whether” to “how” to use AI responsibly, balancing benefits with ethics, privacy and bias. Digital Finance & Fraud: Bank of Valletta ran a fraud-prevention webinar for business customers, stressing AI-enabled scams and the need for informed, vigilant users.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
